Insider Title Company Date Price Return Shares Value
Kersten Dirk Non-Executive Director Dyne Therapeutics, Inc. (DYN) 2024-01-09 $17.50 92.3% 1,714,285 $29,999,988
Return Profit / (loss) Cost
Total 92.3% $27,685,706 $29,999,988